CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 66 enrolled
Drug / intervention
Calcipotriene +1 moredrug
Likely dose
Calcipotriene 1gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01694433
NCT01694433Phase 3Completed
CompareCT.gov

Innate Immunity in Acne Vulgaris

University of California, Los Angeles·interventional·Posted Sep 27, 2012·Updated May 7, 2019

In Brief

A Phase 3 clinical trial evaluating Calcipotriene and Placebo for Acne Vulgaris. Completed, enrolled 66 participants across 1 site.

Detailed Summary

The purpose of this study is to study the effects of topical Vitamin D cream (Calcipotriene, also known as Dovonex) on acne. The information gained from this study may lead to new treatments for acne. In this study, Calcipotriene will be compared with a placebo, a cream that looks like Calcipotriene, but contains no active ingredients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 27, 2012
Enrollment StartFeb 1, 2013
Primary CompletionJan 9, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.8 years ago

Interventions

Calcipotrienedrug

1g daily BID

Placebodrug

1g daily BID